破伤风
破伤风虽可通过高效疫苗预防,但全球每年仍造成3万至5万例死亡,自1980年代以来死亡率因广泛接种大幅下降,但成人病例持续存在,尤其见于免疫应答减弱者、糖尿病患者和注射毒品者。诊断仍为临床诊断,管理结合伤口清创、抗生素和抗毒素;近期试验提示人源与马源抗毒素效果相当,但短缺和高成本持续存在。自主神经不稳定曾被认为是晚期并发症,现定义于疾病早期并影响预后;患者因重症监护可发生医院获得性感染等并发症,增加疾病负担。
要点
- 全球每年破伤风死亡3万至5万例,成人病例持续存在,尤其见于免疫应答减弱者、糖尿病患者和注射毒品者。
- 诊断仍为临床诊断,管理结合伤口清创、抗生素和抗毒素。
- 近期试验提示人源与马源抗毒素效果相当,但短缺和高成本持续存在。
- 自主神经不稳定现定义于疾病早期,影响预后。
- 患者因重症监护可发生医院获得性感染等并发症,增加疾病负担。
适用人群与场景
- 成人破伤风患者,尤其见于免疫应答减弱者、糖尿病患者和注射毒品者。
- 患者需重症监护治疗。
处置流程与药物剂量
- 管理结合伤口清创、抗生素和抗毒素。
- 近期试验提示人源与马源抗毒素效果相当。
红旗征与不能漏的情况
- 自主神经不稳定现定义于疾病早期,影响预后。
- 患者因重症监护可发生医院获得性感染等并发症,增加疾病负担。
证据类型、等级与局限
- 证据类型:综述。
- 近期试验提示人源与马源抗毒素效果相当。
对床旁实践的改变
- 成人破伤风患者需重症监护,警惕医院获得性感染等并发症。
- 自主神经不稳定在疾病早期即出现,需早期识别以影响预后。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「研究设计与关键结果」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Tetanus, although preventable by a highly effective vaccine, continues to cause 30 000-50 000 deaths annually. Global mortality has fallen substantially since the 1980s due to widespread vaccination efforts, yet adult disease persists, especially among those with weakened immune response, diabetes, and people who inject drugs. Diagnosis is still clinical, and management combines wound debridement, antibiotics, and antitoxin. However, key questions about prevention, diagnosis, and management remain unanswered. Recent trials suggest human and equine antitoxin perform equally, but shortages and high costs persist. Autonomic instability, once thought a late stage complication, is now defined early in the disease course, affecting the prognosis. Due to patients being in intensive care, complications such as nosocomial infections can increase the burden of the disease, reinforcing that vaccination, surveillance, equitable access, and new therapy options are vital.
参考来源
- Ergönül Ö, Kolsuz S, Figueroa JP, et al. Tetanus. Lancet. 2026. PMID: 41544646. doi:10.1016/S0140-6736(25)01579-X
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。